Procter & Gamble heads into its October 13 earnings print with short sellers largely absent, the Street turning more cautious, and retail attention running well above its recent norm.
Short interest has extended the retreat documented in the previous note. SI now stands at roughly 1.04% of the free float, down a further 14.4% on the week and off 10.3% over the past month. At 24.4 million shares, the position is trivially small for a stock of this size. Borrow conditions confirm the lack of conviction: availability is essentially uncapped, with 2.3 billion shares still available to lend against a fraction borrowed, and the cost to borrow at 0.32% is barely above zero despite roughly doubling over the past week. That cost-to-borrow move looks more like noise in a very thin lending market than a signal of fresh short demand. The short score of 30.4 has drifted lower all week, ranking in the 70th percentile across the universe, meaning the data is not flagging this as a name where bears are pressing. Options positioning is similarly muted. The put/call ratio closed at 0.71, just above its 20-day average of 0.69 and less than one standard deviation from the mean. With the 52-week high at 1.11 and the low at 0.59, current positioning is squarely in the middle of its range. Neither side is betting hard ahead of the print.
The more interesting tension is on the Street. Analyst direction has tilted toward caution since the July quarter results. HSBC downgraded to Hold and cut its target from $182 to $149 in late July, a meaningful reset. TD Cowen reiterated Hold at $150 this week. Argus downgraded to Hold in August. The bulls still exist: Citi holds Buy at $170, JPMorgan holds Overweight at $162, and Bank of America maintains Buy at $166. But the recent flow is toward the sidelines, not toward conviction longs. The mean price target of $160.61 implies about 8% upside from the current $148.32 close, a gap that feels modest for a stock trading at 20.3 times earnings and 6.1 times book. The dividend yield factor scores at the 98th percentile, confirming PG's standing as a yield anchor. Forward EPS growth is ranked at the 86th percentile year-on-year. Where PG lags is valuation efficiency, with the EV/EBIT score in the 32nd percentile, and near-term earnings momentum, with the 30-day EPS momentum rank at 39. The bear case carries weight: SK-II sales in Greater China fell 30%, and US category growth rates dropped 15% in December, flagging that the top-line environment is uneven.
One data point worth noting is retail attention. The ORTEX alt data layer shows Wikipedia page views running at a z-score of 2.41 relative to PG's own 90-day history, the highest retail attention reading in the dataset window. This is an attention signal, not a revenue indicator, and no dataset in the coverage universe has been measured to lead PG's reported figures. What it does confirm is that the stock is drawing more eyes than usual in the two weeks before the print.
Peer context adds a mild note of caution. CL fell 0.68% on the week and CHD dropped 1.2%, while CLX fell a sharper 6.4%. KMB was the outlier, up fractionally. PG's own 0.07% weekly gain puts it at the stronger end of the peer group, though that reflects less momentum than it does the stock's low-volatility character.
The last two earnings prints both sent the stock lower: down 3.3% on the day after July 2026 results and down 1.7% after the April 2026 report. With the next print arriving October 13, the question is whether a Street that has moved incrementally to the sidelines and a market where consumer spending signals are mixed will reassess those targets, or whether the dividend yield and defensive positioning at a modest premium to the peer group prove sufficient.
See the live data behind this article on ORTEX.
Open PG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.